-
IP in the Economy
The U.S. biopharmaceutical industry powers the nation’s research and development (R&D) economy and helps keep America at the forefront of advanced technology development. The industry ranks first in its share of total manufacturing R&D employment among all U.S. manufacturing industries, and is responsible for about one out of every six dollars spent on R&D by U.S. businesses. The biopharmaceutical industry also is a key generator of new intellectual property and attracts major venture capital investment.
The biopharmaceutical industry is directly responsible for more than 850,000 jobs and a total of 4.4 million total jobs (direct, indirect and induced).
-
IP and Innovation
Biopharmaceutical intellectual property (IP) protections, such as patents and data protection, provide the incentives that spur R&D. They help ensure that the innovative biopharmaceutical companies that have invested in life-saving medicines have an opportunity to justify their investments.
The U.S. IP infrastructure sustains continuing investments and provides the apparatus necessary to funding research into new treatments and cures for our most costly and challenging diseases.
-
IP and International
-
IP and Treatment Options for Patients
-